NCT07093528Recruiting
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
CMR Substudy of Coronary Sinus Reducer for the Management of Symptomatic Heart Failure With a Preserved Ejection Fraction (HFpEF) Associated With Coronary Microvascular Dysfunction (CMD)
Source: ClinicalTrials.gov · Last updated 27 Feb 2026
Brief summary (registry, in English)
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 25 (estimated)
- First submitted
- 23 Jul 2025
- Start date
- Oct 2025
- Primary completion date
- Aug 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Heart failure
- NCT number
- NCT07093528
What you commit to
- Study type: Observational
- Planned participants: 25
- From Oct 2025 to the primary completion date, Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Metal implants that are not suitable for MRI
Other
- Inability or unwillingness of individual to give written informed consent.
Who the study is looking for
- Age ≥18
- Enrollment in main CS-reducer HFPEF study IRB# 25-002292
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.